Dave Lennon’s CEO adventure goes from preclinical to commercial; GSK vet embarks on new Odyssey with Gary Glick

Af­ter step­ping in­to the CEO post for the first time about two years ago, tak­ing over the helm of “tis­sue ther­a­peu­tics” start­up Satel­lite Bio, Dave Lennon is ready to take on his next chal­lenge in the C-suite.

On Mon­day, he trad­ed hats from the pre­clin­i­cal Boston start­up for the com­mer­cial-stage Los An­ge­les drug­mak­er Aa­di Bio­science. About a year and a half in­to the launch of its ul­tra-rare sar­co­ma drug Fyarro, Aa­di has big la­bel ex­pan­sion plans.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.